{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:33:25Z","timestamp":1790940805712,"version":"4.1.0"},"reference-count":18,"publisher":"Institute of Physiology of the Czech Academy of Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"published-print":{"date-parts":[[2011,4,30]]},"abstract":"<jats:p>Cortisone acetate test was performed in twelve young adult patients with diabetes mellitus type 1, after dexamethasone administration to suppress endogenous cortisol production. Previous screening revealed that all of the subjects had peak cortisol responses in the range from subnormal to normal, as determined by a low-dose Synacthen test. The aim was to find out whether these patients would exhibit different conversion of cortisone to cortisol by 11\u03b2-hydroxysteroid dehydrogenase. Using multifactorial ANOVA the following significant relationships were obtained between cortisol or cortisol\/cortisone ratio measured during the test and other parameters examined a) before dexamethasone suppression and b) during the test: a) Cortisol at 120th minute negatively correlated with daily insulin dose and positively with basal aldosterone. Cortisol\/cortisone ratio at 60th, 120th, 180th, and 240th minute negatively correlated with basal aldosterone\/plasma renin activity ratio, urinary free cortisol\/24 hours and positively with basal dehydroepindrosterone sulphate. b) Cortisol at 120th minute negatively correlated with suppressed basal serum glycemia; cortisol\/cortisone ratio during the whole test negatively correlated with supressed basal ACTH. The examination of peripheral metabolism of cortisol using cortisone acetate test in patients with diabetes mellitus type 1 showed adaptive changes of 11\u03b2-hydroxysteroid dehydrogenace activity associated with altered cortisol tissue supply.<\/jats:p>","DOI":"10.33549\/physiolres.932079","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T14:21:01Z","timestamp":1575037261000},"page":"263-270","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of Hepatic 11 \u03b2-Hydroxysteroid Dehydrogenase Activity by Cortisone Acetate Test in Young Adults With Diabetes Mellitus Type 1"],"prefix":"10.33549","author":[{"given":"K.","family":"\u0160IM\u016eNKOV\u00c1","sequence":"first","affiliation":[{"name":"Third Department of Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"HAMPL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"HILL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"K\u0158\u00cd\u017d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"VRB\u00cdKOV\u00c1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"KVASNI\u010cKOV\u00c1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"VONDRA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"19169","published-online":{"date-parts":[[2011,4,16]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"AGHA A, MONSON JP: Modulation of glucocorticoid metabolism by the growth hormone-IGF-1 axix. Clin Endocrinol (Oxf) 66: 459-65, 2007.","DOI":"10.1111\/j.1365-2265.2007.02763.x"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"ANDREWS RC, HERLIHY O, LIVINGSTONE DEW, ANDREW R, WALKER BR: Abnormal Cortisol Metabolism and Tissue Sensitivity to Cortisol in Patients with Glucose Intolerance. J Clin Endocrinol Metab 87: 5587-5593, 2002.","DOI":"10.1210\/jc.2002-020048"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"FIILIPOVIC D, GAVRILOVIC L, DRONJAK S, RADOJCIC MB: Liver glucocorticoid receptor and heat shock protein 70 levels exposed to different stress model. Physiol Res 57: 205-213, 2008.","DOI":"10.1159\/000084168"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"MAI K, ANDRES, BOBBERT J, MASER-GLUTH TC, MOHLI M, BAHR V, PFEIFFER AF, SPRANGER J, DIEDERICH S: Rosiglitazone decreases 11 beta-hydroxysteroid dehydrogenace type 1 in subcutaneous adipose tissue. Clin Endocrinol (Oxf) 67: 419-425, 2007.","DOI":"10.1111\/j.1365-2265.2007.02903.x"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"MOORE JS, MONSON JP, KALTSAS GP, PUTIGNANO P, WOOD PJ, SHEPPARD MC, BESSER GM, TAYLOR NF, STEWART PM: Modulation of 11 beta-hydroxysteroid dehydrogenase isoenzymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies. J Clin Endocrinol Metab 84: 4172-4177, 1999.","DOI":"10.1210\/jcem.84.11.6108"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"PAISLEY AN, ROWLES SV, BRANDON D, TRAINER PJ: A Subnormal Peak Cortisol Response to Stimulation Testing Does Not Predict a Subnormal Cortisol Production Rate. J Clin Endocrinol Metab 94: 1757-1760, 2009.","DOI":"10.1210\/jc.2008-2392"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"PUTIGNANO P, PECORI GIRALDI F, CAVAGNINI F: Tissue-specific dysregulation of 11\u00df-hydroxysteroid dehydrogenase type 1 and pathogenesis of the metabolic syndrome. J Endocrinol Invest 27: 969-974, 2004.","DOI":"10.1007\/bf03347544"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"RASK E, WALKER BR, SODERBERG S, DAWN E, LIVINGSTONE DEW, ELIASSON M, JOHNSON O, ANDREW R, OLSSON T: Tissue-Specific Changes in Peripheral Cortisol Metabolism in Obese Women: Increased Adipose 11beta Hydroxysteroid Dehydrogenace Type 1 Activity. J Clin Endocrinol Metab 87: 3330-3336, 2002.","DOI":"10.1210\/jcem.87.7.8661"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"REICHARDT MH, BRONCHE F, BAUER A, SCHULZ G: Molecular genetic analysis of glucocorticoids signaling using the Cre\/ioxP syst\u00e9m. Biol Chem 381: 961-964, 2000.","DOI":"10.1515\/BC.2000.118"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"REYNOLDS RM, WALKER BR: Human insulin resistance: the role of glucocorticoids. Diab Obes Metab 5: 5-12, 2003.","DOI":"10.1046\/j.1463-1326.2003.00221.x"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"\u0160IM\u016eNKOV\u00c1 K, HAMPL R, HILL M, K\u0158\u00cd\u017d L, HRD\u00c1 P, JANI\u010cKOV\u00c1-\u017dD\u00c1RSK\u00c1 D, ZAMRAZIL V, VRB\u00cdKOV\u00c1 J, VONDRA K: Adrenocortical function in young adults with diabetes mellitus type 1. J Steroid Biochem Mol Biol 122: 35-41, 2010.","DOI":"10.1016\/j.jsbmb.2010.04.017"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"STEWART PM, BOULTON A, KUMAR S, CLARK PMS, SHACKLETON CH: Cortisol Metabolism in Human Obesity: Impaired Cortisone - Cortisol Conversion in Subjects with Central Adiposity. J Clin Endocrinol Metab 84: 1022-1027, 2005.","DOI":"10.1210\/jc.84.3.1022"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"STEWART PM, TOOGOOD AA, TOMLINSON JW: Growth hormone, insulin-like growth factor-1 and the cortisol-cortisone shuttle. Horm Res 56 (Suppl 1): 1-6, 2001.","DOI":"10.1159\/000048126"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"TOMLINSON JW, WALKER EA, BUJALSKA I, DRAPER N, LAVERY GG, COOPER MS, HEWISON M, STEWART PM: 11\u00df-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocrine Rev 25: 831-866, 2004.","DOI":"10.1210\/er.2003-0031"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"TEN S, NEW M, MACLAREN N: Clinical Review 130: Addison\u2019s Disease 2001. J Clin Endocrinol Metab 86: 2909-2922, 2001.","DOI":"10.1210\/jcem.86.7.7636"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"VALSAMAKIS G, ANWAR A, TOMLINSON JW, SHACKLETON CHL, MCTERNAN PG, CHETTY R, WOOD PJ, BANERJEE AK, HOLDER G, BARNETT AH, STEWART PM, KUMA S: 11\u00df-hydroxysteroid dehydrogenase type 1 in lean and obese males with type 2 diabetes mellitus. J Clin Endocrinol Metab 89: 4755-4761, 2004.","DOI":"10.1210\/jc.2003-032240"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"WAKE DJ, WALKER BR: 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Mol Cell Endocrinol 215: 45-54, 2004.","DOI":"10.1016\/j.mce.2003.11.015"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"WESTERBACKA J, YKI-JARVINEN H, VEHKAVAARA S, HAKKINEN AM, ANDREW R, WAKE DJ, SECKL JR, WALKER BR: Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol\/cortisone metabolite ratios in men with fatty liver. J Clin Endocrinol Metab 88: 4924-4931, 2003.","DOI":"10.1210\/jc.2003-030596"}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T14:21:07Z","timestamp":1575037267000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomed.cas.cz\/physiolres\/pdf\/60\/60_263.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,16]]},"references-count":18,"URL":"https:\/\/doi.org\/10.33549\/physiolres.932079","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4,16]]}}}